Early disclosure of AD blood biomarker results increases diagnostic certainty and leads to earlier, more targeted clinical ...

A two-year study of 506 older adults in the COSMOS cohort found that plasma biomarkers of neurodegeneration, including NT1, ...

A large global study provides new evidence supporting the use of blood biomarkers in an Alzheimer's clinical trial to screen for elevated brain amyloid levels among potential participants who are ...

Please provide your email address to receive an email when new articles are posted on . Time from biopsy to receipt of molecular testing results decreased, but most of the improvement occurred at the ...

Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest ...

Biomarker profiles are tumor-specific and can predict sensitivity or resistance to targeted therapy or immune checkpoint inhibition, enabling more individualized treatment selection than histology ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

Precision medicine relies on biomarker testing to match therapies to specific cancers, yet many patients remain untested due to standardization issues. Recommendations include educating clinicians, ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Automation, digital platforms, biomarker testing, global lab expansion, and pharma partnerships drive efficiency and capture rising clinical trial demand.Dublin, Oct. (GLOBE NEWSWIRE) -- "Central Lab ...

Please provide your email address to receive an email when new articles are posted on . Biomarker testing appeared inconsistent, with rates not reflecting guidelines. Less than 25% of oncologists ...

The U.S. Biomarker Testing Market is estimated to be worth USD 11.67 billion in 2025 and is projected to increase at a compound annual growth rate (CAGR) of 2.25% from 2026 to 2035, reaching USD 14.57 ...